CD44 and breast carcinoma: Thus, the dormant CD44-/CD24- breast cancer cells that have previously been colonized in the metastatic site may be able to spontaneously convert into CD44+/CD24- breast CSCs to regain their potent proliferative ability and drug resistance, resulting in delayed breast cancer metastasis.